Orphalan
Clinical trials sponsored by Orphalan, explained in plain language.
-
New Once-Daily pill for Wilson's disease tested for patient preference
Symptom relief CompletedThis study looked at whether people with Wilson's disease prefer a new once-daily medicine (trientine 4HCl) over their usual treatment, which is taken twice or more each day. Ten adults completed the study, which measured satisfaction, convenience, and adherence through questionn…
Phase: PHASE2 • Sponsor: Orphalan • Aim: Symptom relief
Last updated May 17, 2026 12:29 UTC
-
New blood test could Fine-Tune Wilson's disease treatment
Knowledge-focused CompletedThis study looked at a new blood test that measures copper levels in people with Wilson's disease, a rare condition where copper builds up in the body. Researchers collected extra blood samples from 50 adults during routine visits over a year. The goal was to see if this test hel…
Sponsor: Orphalan • Aim: Knowledge-focused
Last updated May 17, 2026 12:26 UTC